Year: 2020

HALIFAX, Nova Scotia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) (“Erdene“ or the “Company”) is pleased to announce operating and financial results for the three and nine months ended September 30, 2020 and to provide an update on the Bayan Khundii Gold Project. This release should be read in conjunction with the Company’s Q3-2020 Financial Statements, MD&A and Annual Information Form, available on the Company’s website or SEDAR.Quotes from the Company:“We made significant progress during the third quarter on our two core objectives of advancing the Bayan Khundii Gold Project (“Bayan Khundii” or “BK”) towards development and expanding high-grade gold resources in the Khundii Gold District,” said Peter Akerley, Erdene’s President and CEO.“The recently announced...

Company to host conference call and webcast on Thursday, November 19 at 8:30 am EDTLYON, France, November 9, 2020 – EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter ended September 30, 2020 after the markets close on Wednesday, November 18, 2020.An accompanying conference call and webcast will be conducted by Marc Oczachowski, Chairman of the Board and Chief Executive Officer, and François Dietsch, Chief Financial Officer. The call will be held at 8:30am EDT on Thursday, November 19, 2020. Please refer to the information below for conference call dial-in information and webcast registration.Conference Call & WebcastThursday, November 19th @ 8:30am Eastern TimeDomestic:                    877-451-6152International:             ...

Las Vegas, NV, Nov. 09, 2020 (GLOBE NEWSWIRE) — Earth Gen-BioFuel Inc. (OTC:EGBB) announces that it has joined local community and business leaders in the effort to assist people who lost their homes due to Oregon area wildfires. The company’s 70,000 square foot manufacturing facility and offices were the site of last weeks meeting of community leaders, business executives and mayors from nearby communities that experienced fire damage. KGW Channel 8 TV Portland was there to report on the event.Earth Gen’s subsidiary, International Housing Concepts Inc. (“IHC”) specializes in manufacturing homes of less than 1,000 square feet. IHC is building homes that are used in Tiny Home Residential Communities, RV Parks, Campgrounds and as back yard auxiliary living units. IHC also builds 300 to 380 square foot towable Tiny Homes that operate...

COLUMBUS, Ohio, Nov. 09, 2020 (GLOBE NEWSWIRE) — Worthington Industries, Inc. (NYSE: WOR) announced today that Joe Hayek, Vice President and CFO, will present at Baird’s 2020 Virtual Global Industrials Conference on Nov. 12 at 12:50 p.m. ET. He will provide investors with an update on the Company’s operations, financial performance and growth strategy.A live webcast of the event can be accessed at https://kvgo.com/baird-global-industrials/wor-november-2020 or on the Worthington Industries website at ir.worthingtonindustries.com and will be available for replay for one year. About Worthington IndustriesWorthington Industries (NYSE:WOR) is a leading industrial manufacturing company delivering innovative solutions to customers that span many industries including transportation, construction, industrial, agriculture, retail and energy....

Gaithersburg, MD, Nov. 09, 2020 (GLOBE NEWSWIRE) — Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS) is pleased to provide this update on the strong growth trends in its Pachyderm Labs division (“Pachyderm”). The Company is excited to report that it has sold out the majority of its CBD product inventory and now has a backlog of orders that will be fulfilled following the next production run.As previously reported, Pachyderm recently attended a major industry expo in Florida, its first trade show in many months. The team primarily used this trade show as a networking event to show off newly designed packaging to potential customers. Feedback of the new branding was overwhelmingly positive. Even without a booth presence, the team secured three large initial orders totaling close to $200,000, in addition to smaller...

MONTREAL, Nov. 09, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Tuesday, November 17, 2020 to discuss the Company’s financial results for the fiscal 2021 second quarter ended September 30, 2020, as well as the Company’s corporate progress and other developments. The Company expects to file its financial statements along with its MD&A post market on November 16, 2020.The conference call will be available via telephone by dialing toll free 844-369-8770 for Canadian and U.S. callers or +1 862-298-0840 for international callers, or on the Company’s Investor Events section of the website: https://www.medexus.com/en_US/investors/news-events.A webcast replay will be available...

IRVINE, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — The 2020 holiday season is fast approaching, and this year, brands, retailers and consumers are preparing for major changes related to holiday celebrations, spending and gifting, according to “The 2020 Challenge: Keeping Spirits Bright This Holiday Season,” a new report by Advantage Sales, a division of Advantage Solutions.Nearly nine in 10 consumers cited that COVID-19 has impacted their holiday plans, according to the report, which is based on the responses of 1,027 adults, each of whom typically participates in at least one of the major winter holidays, including Black Friday and Cyber Monday. Participant responses were fielded between September 16 and September 22, 2020 by Advantage Sales’ SMARTeam.“Communities across the nation are seeing a holiday season like never before,”...

FLORHAM PARK, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced financial results for the third quarter ended September 30, 2020 and provided a corporate update.Third Quarter and Recent Corporate HighlightsHeld FDA Type B guidance meeting to define the registrational pathway for our priority adult hematology oncology indications and planned initiation of the pivotal study for our lead indication in the fourth quarterAnnounced CLR 131 achieved a 40% overall response rate (ORR) in Triple Class Refractory Multiple Myeloma (MM) patients with an administered total body dose (TBD) of 60mCi or greater from the Phase 2 CLOVER-1 studyInterim results...